Clinical Trial

Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 1, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Imaging of proinflammatory activated microglia by Purine 2X7 (P2X7) receptor scintigraphy in Positron Emission Tomography (PET) scanner in Glioblastoma patients.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-02-23; most recent amendment 2025-03-26.
Status change: Recruiting → Active, Not Recruiting 2025-03-26
Status change: Not Yet Recruiting → Recruiting 2024-03-05
Trial Details
NCT Number NCT05753995
Lead Sponsor Kepler University Hospital
Conditions Glioblastoma
Enrollment 20 participants
Start Date 2024-03-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-01